Lymphocyte membrane receptors in human lymphoid leukemias

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Leukemia involves abnormal white blood cell proliferation.
• Distinguishing between B cell and T cell malignancies is crucial for diagnosis and treatment.
• Cell surface markers are key for identifying lymphocyte subtypes and their abnormalities.

Purpose of the Study:

• To investigate the expression of B cell and T cell membrane markers in patients with chronic lymphatic leukemia (CLL), acute lymphoblastic leukemia (ALL), and Sézary syndrome.
• To compare marker expression in leukemia patients with normal lymphocyte populations.

Main Methods:

• Utilized B cell membrane markers: membrane-bound immunoglobulins, Fc fragment of IgG receptors, and complement component C3 receptors.
• Employed T cell membrane marker: spontaneous rosette formation with sheep erythrocytes.
• Analyzed peripheral blood lymphocytes from 22 CLL patients, 5 ALL patients, and 1 Sézary syndrome patient.

Main Results:

• Nineteen of twenty-seven (70%) CLL or ALL cases exhibited a higher percentage of cells expressing at least one B cell marker compared to normal individuals.
• The patient with Sézary syndrome displayed an increased percentage of T cells forming spontaneous rosettes.
• The Sézary syndrome patient had B cell marker expression below normal values.

Conclusions:

• Elevated B cell surface markers are common in chronic lymphatic leukemia and acute lymphoblastic leukemia.
• Sézary syndrome is characterized by increased T cell activity and decreased B cell activity.
• Immunophenotyping using cell surface markers aids in differentiating lymphoid malignancies.